6058 Phase I/II study of weekly intermittent capecitabine with bevacizumab and oxaliplatin on an every-2-week schedule for patients with untreated advanced colorectal cancer (CRC) final results

✍ Scribed by Ramanathan, R.K.; Sehgal, R.; Rajasenan, K.K.; Crandall, T.L.; Balaban, E.P.; Pinkerton, R.A.; Kane, P.; Potter, D.M.; Lembersky, B.C.

• Book ID: 123561235
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71153-X